Avoid injecting into bruised, red, scarred, or hardened skin , and record injection sites to help identify any recurring local reactions early
Statistics and reproducibility The phase 2 clinical trial was powered to show a difference in proportions of 28% on primary endpoint MASH resolution and no worsening of fibrosis between once-daily semaglutide 0.4 mg (assumed 45% response) and placebo (assumed 17% response)
The findings identify an FXR/PXR-driven cross-talk pathway that links lipid and amino-acid metabolism and provide a mechanistic rationale for BBBP in NASH therapy (Jiang et al., 2023)
Therefore, assay for reduced activity of this enzyme, in red blood cell lysates, is highly diagnostic in cases of suspected thiamine deficiency
Harris-Tryon TA, Grice EA
Semaglutide might not be suitable for people with a family history of specific cancers or severe gastrointestinal diseases